Hippocratic AI

Overview

Hippocratic AI develops "the safest generative AI healthcare agent for patient interactions." Built on the proprietary Polaris Constellation architecture, the agents do not diagnose or prescribe — they focus on chronic care and post-discharge follow-up. By 2026, they completed 150M+ clinical interactions with 50+ partners worldwide.

Key Features

Polaris Constellation

Proprietary multi-model architecture focused on consistency, safety, and empathy to augment care teams.

Safety-First Design

• No diagnosis
• No prescribing
• Strict guardrails against misinformation
• Support care teams

Patient-Facing Agents

• Chronic care (diabetes, hypertension follow-up)
• Post-discharge monitoring
• Medication reminders
• Appointment support
• Health education

2026 Updates

• Acquired Grove AI to expand into pharma/medtech
• Strategic partnership with BCG for biopharma/medtech agentic AI
• Collaborating with 5 of the top 20 global pharma companies
• $126M Series C funding

Pricing

Enterprise-only — no public pricing. Custom contracts for health systems, payors, and pharma.

Strengths

• ✅ Polaris Constellation architecture
• ✅ 150M+ clinical interactions
• ✅ Safety-first (no diagnosis/prescribing)
• ✅ Top pharma collaborations
• ✅ BCG strategic partnership
• ✅ $126M Series C raised

Weaknesses

• ❌ Enterprise-only
• ❌ Limited Japan presence
• ❌ English-focused
• ❌ Opaque pricing

Official Resources

• Website: https://hippocraticai.com